Results 121 to 130 of about 32,832 (202)
Research on Targeted Therapy for Malignant Tumors of the Biliary Tract. [PDF]
Yang Y, Zhong H, Zhang J, Wang P.
europepmc +1 more source
Recurrent Resistance Mutations to Lirafugratinib Inform Treatment Sequencing in FGFR2-Driven Tumors. [PDF]
Facchinetti F +35 more
europepmc +1 more source
FGFR1 and FGFR2 are amplified in many tumor types, yet what determines response to FGFR inhibition in amplified cancers is unknown. In a translational clinical trial, we show that gastric cancers with high-level clonal FGFR2 amplification have a high ...
Chua S +26 more
core
Fibroblast Growth Factor Receptor (FGFR) Inhibitors for the Treatment of Cholangiocarcinoma: Key Therapeutic Developments and Knowledge Gaps. [PDF]
Erul E +7 more
europepmc +1 more source
Clinical and Genetic Landscape of Glioblastoma, IDH-Wildtype With FGFR Gene Family Alterations. [PDF]
Kegoya Y +9 more
europepmc +1 more source
Design and synthesis of an erdafitinib-based selective FGFR2 degrader. [PDF]
Jin Y +7 more
europepmc +1 more source
From blunt tools to bullseyes: The impact of targeted therapy in pediatric neuro-oncology. [PDF]
Bennett J, Bouffet E.
europepmc +1 more source

